About
Jim Woody has over 30 years of pharmaceutical research and management experience. He was founding CEO of OncoMed Pharmaceuticals and previously served as President and General Manager of Roche Bioscience and as Chief Scientific Officer and SVP of R&D at Centocor, where he helped develop Remicade and ReoPro. Earlier, he was a Navy Medical Officer who helped found the National Marrow Donor Program; he holds an M.D. from Loma Linda University and a Ph.D. in Immunology from the University of London.
Invests in
BiotechHealthtech
Investments
Board seats
ForteBioProteinSimple
Investor
OncoMed Pharmaceuticals
Per the firm's website.